Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13502)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(31): 7006-7016 [PMID: 27610012 DOI: 10.3748/wjg.v22.i31.7006] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i31/7006.htm |
| Number | Citing Articles |
| 1 |
Elena Grasselli, Laura Canesi, Piero Portincasa, Adriana Voci, Laura Vergani, Ilaria Demori. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. Annals of Hepatology 2017; 16(5): 707 doi: 10.5604/01.3001.0010.2713
|
| 2 |
Mahmoud Samy Abdallah, Ahmed Hossam Eldeen, Sally Said Tantawy, Tarek Mohamed Mostafa. The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial. European Journal of Pharmacology 2021; 906: 174295 doi: 10.1016/j.ejphar.2021.174295
|
| 3 |
Carmela Colica, Luigi Boccuto, Ludovico Abenavoli. Silymarin: An option to treat non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(47): 8437-8438 doi: 10.3748/wjg.v23.i47.8437
|
| 4 |
Razie Hormoznejad, Majid Mohammad Shahi, Fakher Rahim, Bijan Helli, Pezhman Alavinejad, Asaad Sharhani. Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial. International Journal of Food Sciences and Nutrition 2020; 71(8): 991 doi: 10.1080/09637486.2020.1746957
|
| 5 |
Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker, Gema Frühbeck. Towards an adiposity-related disease framework for the diagnosis and management of obesities. Reviews in Endocrine and Metabolic Disorders 2023; 24(5): 795 doi: 10.1007/s11154-023-09797-2
|
| 6 |
Saman Khalatbari-Soltani, Fumiaki Imamura, Soren Brage, Emanuella De Lucia Rolfe, Simon J Griffin, Nicholas J Wareham, Pedro Marques-Vidal, Nita G Forouhi. The association between adherence to the Mediterranean diet and hepatic steatosis: cross-sectional analysis of two independent studies, the UK Fenland Study and the Swiss CoLaus Study. BMC Medicine 2019; 17(1) doi: 10.1186/s12916-019-1251-7
|
| 7 |
Fatemeh Maleki Sedgi, Mohammadreza Mohammad Hosseiniazar, Mohammad Alizadeh. The effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance and anthropometric measurements in patients with non-alcoholic fatty liver disease: a randomised controlled clinical trial. British Journal of Nutrition 2024; 131(12): 1985 doi: 10.1017/S0007114524000564
|
| 8 |
Moloud Fakhri, Hafez Fakheri, Mohammad Azadbakht, Mahmood Moosazadeh, Seyde Sedighe Yousefi. Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran. International Journal of Preventive Medicine 2022; 13(1): 87 doi: 10.4103/ijpvm.IJPVM_313_20
|
| 9 |
Leonardo Recena Aydos, Luane Aparecida do Amaral, Roberta Serafim de Souza, Ana Cristina Jacobowski, Elisvânia Freitas dos Santos, Maria Lígia Rodrigues Macedo. Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models. Nutrients 2019; 11(12): 3067 doi: 10.3390/nu11123067
|
| 10 |
Jing Zeng, Rui-Xu Yang, Chao Sun, Qin Pan, Rui-Nan Zhang, Guang-Yu Chen, Ying Hu, Jian-Gao Fan. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(15): 1792-1804 doi: 10.3748/wjg.v26.i15.1792
|
| 11 |
Nicole Fakhoury Sayegh, Gessica N. H. A. Heraoui, Hassan Younes, Lea Nicole Sayegh, Christa Boulos, Raymond Sayegh. Relation of Dietary Patterns and Nutritional Profile to Hepatic Fibrosis in a Sample of Lebanese Non-Alcoholic Fatty Liver Disease Patients. Nutrients 2022; 14(12): 2554 doi: 10.3390/nu14122554
|
| 12 |
Raghdaa Al Zarzour, Mariam Ahmad, Mohd. Asmawi, Gurjeet Kaur, Mohammed Saeed, Majed Al-Mansoub, Sultan Saghir, Nasiba Usman, Dhamraa Al-Dulaimi, Mun Yam. Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague–Dawley Rats. Nutrients 2017; 9(7): 766 doi: 10.3390/nu9070766
|
| 13 |
Ping Li, Cunxia Fan, Yingying Cai, Shu Fang, Yanmei Zeng, Yudan Zhang, Xiaochun Lin, Hongbin Zhang, Yaoming Xue, Meiping Guan. Transplantation of brown adipose tissue up-regulates miR-99a to ameliorate liver metabolic disorders in diabetic mice by targeting NOX4. Adipocyte 2020; 9(1): 57 doi: 10.1080/21623945.2020.1721970
|
| 14 |
Lei Pan, Lixuan Wang, Huijuan Ma, Fan Ding. Relevance of combined influence of nutritional and inflammatory status on non‐alcoholic fatty liver disease and advanced fibrosis: A mediation analysis of lipid biomarkers. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16760
|
| 15 |
Manuel Suárez, Noemí Boqué, Josep Del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
|
| 16 |
Takuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, Akihiro Obora, Takao Kojima, Michiaki Fukui. Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01809-2
|
| 17 |
Nicole Fakhoury-Sayegh, Hassan Younes, Gessica Heraoui, Raymond Sayegh. Nutritional Profile and Dietary Patterns of Lebanese Non-Alcoholic Fatty Liver Disease Patients: A Case-Control Study. Nutrients 2017; 9(11): 1245 doi: 10.3390/nu9111245
|
| 18 |
Orkide Kutlu, Özgür Altun, Okan Dikker, Şerife Aktaş, Neslihan Özsoy, Yücel Arman, Eylem Özgün Çil, Mustafa Özcan, Şengül Aydın Yoldemir, Murat Akarsu, İlkim Deniz Toprak, Kerem Kırna, Yasin Kutlu, Zeki Toprak, Hasan Eruzun, Tufan Tükek. Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. Medical Principles and Practice 2019; 28(5): 463 doi: 10.1159/000500106
|
| 19 |
Anuragh Singh, Vellapandian Chitra, Kaliappan Ilango. Network pharmacology exploration to reveal molecular insights of Phyllanthus niruri in non-alcoholic fatty liver: In vitro and in silico evidence. Pharmacia 2024; 71: 1 doi: 10.3897/pharmacia.71.e124595
|
| 20 |
Sulan Lin, Yajing Xian, Yi Liu, Wen Cai, Jiangmei Song, Xiangyang Zhang. Risk factors and community intervention for nonalcoholic fatty liver disease in community residents of Urumqi, China. Medicine 2018; 97(9): e0021 doi: 10.1097/MD.0000000000010021
|
| 21 |
Xingqi Cao, Yeqing Gu, Shanshan Bian, Qing Zhang, Ge Meng, Li Liu, Hongmei Wu, Shunming Zhang, Yawen Wang, Tingjing Zhang, Xuena Wang, Shaomei Sun, Xing Wang, Qiyu Jia, Kun Song, Kaijun Niu. Association between eating speed and newly diagnosed nonalcoholic fatty liver disease among the general population. Nutrition Research 2020; 80: 78 doi: 10.1016/j.nutres.2020.06.012
|
| 22 |
Ji‐Hye Kwon, Hyeon Gyu Lee, Kun‐Ho Seo, Hyunsook Kim. Combination of Whole Grapeseed Flour and Newly Isolated Kefir Lactic Acid Bacteria Reduces High‐Fat‐Induced Hepatic Steatosis. Molecular Nutrition & Food Research 2019; 63(4) doi: 10.1002/mnfr.201801040
|
| 23 |
Kyoung Hae Kang, Daeun Shin, Ik Hee Ryu, Jin Kuk Kim, In Sik Lee, Kyungmin Koh, Tae Keun Yoo. Association between cataract and fatty liver diseases from a nationwide cross-sectional study in South Korea. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-023-50582-7
|
| 24 |
Emidio Scarpellini, Sharmila Fagoonee, Emanuele Rinninella, Carlo Rasetti, Isabella Aquila, Tiziana Larussa, Pietrantonio Ricci, Francesco Luzza, Ludovico Abenavoli. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. Journal of Clinical Medicine 2020; 9(8): 2488 doi: 10.3390/jcm9082488
|
| 25 |
Won Myung Lee, Jea Hurn Bae, Young Chang, Sae Hwan Lee, Ji Eun Moon, Soung Won Jeong, Jae Young Jang, Sang Gyune Kim, Hong Soo Kim, Jeong-Ju Yoo, Young Seok Kim. Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial. Nutrients 2021; 13(12): 4453 doi: 10.3390/nu13124453
|
| 26 |
Catriona MacLean, John Dillon, John A. Babraj, Niels BJ. Vollaard. The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease. The Physician and Sportsmedicine 2018; 46(1): 87 doi: 10.1080/00913847.2018.1411171
|
| 27 |
Nasrin Sharifi, Reza Amani. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. Critical Reviews in Food Science and Nutrition 2019; 59(4): 693 doi: 10.1080/10408398.2017.1389693
|
| 28 |
Aleksandra Klisic, Nebojsa Kavaric, Ludovico Abenavoli, Verica Stanisic, Vesna Spasojevic-Kalimanovska, Jelena Kotur-Stevuljevic, Ana Ninic. Is endocan a novel potential biomarker of liver steatosis and fibrosis?. Journal of Medical Biochemistry 2019; 0(0) doi: 10.2478/jomb-2019-0042
|
| 29 |
Ayumu Osaki, Kazuki Kagami, Yuki Ishinoda, Atsushi Sato, Toyokazu Kimura, Shunpei Horii, Kei Ito, Takumi Toya, Yasuo Ido, Takayuki Namba, Nobuyuki Masaki, Yuji Nagatomo, Takeshi Adachi. Reactive Oxygen Species in the Aorta and Perivascular Adipose Tissue Precedes Endothelial Dysfunction in the Aorta of Mice with a High-Fat High-Sucrose Diet and Additional Factors. International Journal of Molecular Sciences 2023; 24(7): 6486 doi: 10.3390/ijms24076486
|
| 30 |
Apostolis PAPAEFTHYMIOU, Michael DOULBERIS, Kyriaki KARAFYLLIDOU, Eleftherios CHATZIMICHAEL, Georgia DERETZI, Aristomenis K. EXADAKTYLOS, Fotios SAMPSONAS, Athanasios GELASAKIS, Spyros I. PAPAMICHOS, Georgios KOTRONIS, Dimitra GIALAMPRINOU, Elisabeth VARDAKA, Stergios A. POLYZOS, Jannis KOUNTOURAS. Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. Minerva Endocrinology 2023; 48(3) doi: 10.23736/S2724-6507.21.03564-8
|
| 31 |
CHANGES IN CARBOHYDRATE METABOLISM IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION. International Academy Journal Web of Scholar 2019; (6(36)): 17 doi: 10.31435/rsglobal_wos/30062019/6551
|
| 32 |
Xiaoya Zheng, Wei Ren, Lilin Gong, Jian Long, Rong Luo, Yonghong Wang. The Great Chinese Famine Exposure in Early Life and the Risk of Nonalcoholic Fatty Liver Disease in Adult Women. Annals of Hepatology 2017; 16(6): 901 doi: 10.5604/01.3001.0010.5281
|
| 33 |
Ludovico Abenavoli, Maja Milanović, Nataša Milić, Francesco Luzza, Angelo Maria Giuffrè. Olive oil antioxidants and non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019; 13(8): 739 doi: 10.1080/17474124.2019.1634544
|
| 34 |
Daofei Song, Lei Yin, Chang Wang, Xiuying Wen. Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-019-2811-2
|
| 35 |
Ludovico Abenavoli, Natasa Milic, Francesco Luzza, Luigi Boccuto, Antonino De Lorenzo. Polyphenols treatment in patients with nonalcoholic fatty liver disease. Journal of Translational Internal Medicine 2017; 5(3): 144 doi: 10.1515/jtim-2017-0027
|
| 36 |
Marco A. Perrone, Paola Gualtieri, Santo Gratteri, Wahid Ali, Domenico Sergi, Saverio Muscoli, Andrea Cammarano, Sergio Bernardini, Laura Di Renzo, Francesco Romeo. Effects of postprandial hydroxytyrosol and derivates on oxidation of LDL, cardiometabolic state and gene expression: a nutrigenomic approach for cardiovascular prevention. Journal of Cardiovascular Medicine 2019; 20(7): 419 doi: 10.2459/JCM.0000000000000816
|
| 37 |
Maryana SAVYTSKA, Marko KOZYK, Kateryna STRUBCHEVSKA, Kateryna YOSYPENKO, Tetyana FALALYEYEVA, Nazarii KOBYLIAK, Luigi BOCCUTO, Rinaldo PELLICANO, Sharmila FAGOONEE, Emidio SCARPELLINI, Ludovico ABENAVOLI. Association between intestinal microflora and obesity. Minerva Gastroenterology 2024; 70(3) doi: 10.23736/S2724-5985.23.03379-X
|
| 38 |
Ping Hao, Xiaonan Yang, Wen Yin, Xinyi Wang, Yun Ling, Mengyao Zhu, Yue Yu, Shouhai Chen, Yuan Yuan, Xiaoyu Quan, Zhiheng Xu, Jiahui Zhang, Wenjia Zhao, Ying Zhang, Chunlian Song, Qing Xu, Shuangshuang Qin, Yi Wu, Xianghua Shu, Kunhua Wei. A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota. Frontiers in Veterinary Science 2024; 11 doi: 10.3389/fvets.2024.1383801
|
| 39 |
Mohamed M. Elseweidy, Sousou I. Ali, Noura I. Shershir, Abd Elmonem A. Ali, Sally K. Hammad. Vitamin D3 intake as modulator for the early biomarkers of myocardial tissue injury in diabetic hyperlipidaemic rats. Archives of Physiology and Biochemistry 2022; 128(3): 628 doi: 10.1080/13813455.2020.1716015
|
| 40 |
Fangbo Zhang, Yu Li, Weijuan Xin, Lifang Wang, Yi Zhang, He Xu, Hongjie Wang, Haiyu Zhao, Hongjun Yang, Nan Si, Baolin Bian. Gypenosides and capsaicinoids in combination ameliorates high-fat-diet- induced rat hyperlipidemia via the PPARγ-LXRα-ABCA1/ABCG1 pathway. Journal of Functional Foods 2023; 108: 105714 doi: 10.1016/j.jff.2023.105714
|
| 41 |
Ludovico Abenavoli, Anna C. Procopio, Milica Medić-Stojanoska, Francesco Luzza. Non-alcoholic fatty liver disease and primary care physicians. Minerva Gastroenterologica e Dietologica 2020; 66(1) doi: 10.23736/S1121-421X.20.02666-5
|
| 42 |
Shira Zelber‐Sagi, Federico Salomone, Liat Mlynarsky. The Mediterranean dietary pattern as the diet of choice for non‐alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver International 2017; 37(7): 936 doi: 10.1111/liv.13435
|
| 43 |
Katharina Mörwald, Elmar Aigner, Peter Bergsten, Susanne M. Brunner, Anders Forslund, Joel Kullberg, Hakan Ahlström, Hannes Manell, Kirsten Roomp, Sebastian Schütz, Fanni Zsoldos, Wilfried Renner, Dieter Furthner, Katharina Maruszczak, Stephan Zandanell, Daniel Weghuber, Harald Mangge. Serum Ferritin Correlates With Liver Fat in Male Adolescents With Obesity. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00340
|
| 44 |
Yongsang Seo, Gi-Ho Sung, Sangheun Lee, Ki Jun Han. Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease. Annals of Hepatology 2022; 27(3): 100690 doi: 10.1016/j.aohep.2022.100690
|
| 45 |
Maha Hoteit, Myriam Dagher, Nikolaos Tzenios, Najat Al Kaaki, Ghadir Rkein, Abdul Rahman Chahine, Yonna Sacre, Samer Hotayt, Rami Matar, Mahmoud Hallal, Micheal Maitar, Bilal Hotayt. Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study. Healthcare 2024; 12(5): 591 doi: 10.3390/healthcare12050591
|
| 46 |
Bojan Jorgačević, Danijela Vučević, Milena Vesković, Dušan Mladenović, Dušan Vukićević, Rada Ješić Vukićević, Vera Todorović, Tatjana Radosavljević. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology 2019; 97(2): 120 doi: 10.1139/cjpp-2018-0607
|
| 47 |
Karlijn J. Nass, Eline H. van den Berg, Klaas Nico Faber, Tim C.M.A. Schreuder, Hans Blokzijl, Robin P.F. Dullaart. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study. Metabolism 2017; 72: 37 doi: 10.1016/j.metabol.2017.04.004
|
| 48 |
Nataša Milošević, Maja Milanović, Jan Sudji, Dragana Bosić Živanović, Stefan Stojanoski, Bojan Vuković, Nataša Milić, Milica Medić Stojanoska. Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans?. Environmental Science and Pollution Research 2020; 27(1): 772 doi: 10.1007/s11356-019-06831-2
|
| 49 |
Ludovico Abenavoli. Influence of Famine in Women with Non-Alcoholic Fatty Liver Disease. Annals of Hepatology 2017; 16(6): 826 doi: 10.5604/01.3001.0010.5269
|
| 50 |
Maricruz Sepulveda-Villegas, Sonia Roman, Ingrid Rivera-Iñiguez, Claudia Ojeda-Granados, Karina Gonzalez-Aldaco, Luis Alberto Torres-Reyes, Alexis Jose-Abrego, Arturo Panduro, Pavel Strnad. High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population. PLOS ONE 2019; 14(1): e0208926 doi: 10.1371/journal.pone.0208926
|
| 51 |
Diego García-Compeán, Jesús Zacarías Villarreal-Pérez, Manuel Enrique de la O. Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Angel Noé Del Cueto-Aguilera, José Alberto González-González, Consuelo Treviño-Garza, Lourdes Huerta-Pérez, Héctor Jesús Maldonado-Garza. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?. Annals of Hepatology 2020; 19(3): 258 doi: 10.1016/j.aohep.2020.01.003
|
| 52 |
Yuling Xing, Tiantian Cheng, Fei Zhou, Huijuan Ma. The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 269 doi: 10.2147/DMSO.S348870
|
| 53 |
Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers. Metabolites 2022; 12(11): 1073 doi: 10.3390/metabo12111073
|
| 54 |
Ludovico Abenavoli, Tetyana Falalyeyeva, Luigi Boccuto, Olena Tsyryuk, Nazarii Kobyliak. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease. Pharmaceuticals 2018; 11(4): 104 doi: 10.3390/ph11040104
|
| 55 |
Samaneh Hosseinabadi, Maryam Rafraf, Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Shohreh Vojouhi. Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Complementary Therapies in Medicine 2020; 49: 102290 doi: 10.1016/j.ctim.2019.102290
|
| 56 |
S. Kahan, A. Cuker, R. F. Kushner, J. Maahs, M. Recht, T. Wadden, T. Willis, S. Majumdar, D. Ungar, D. Cooper. Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelines. Haemophilia 2017; 23(6): 812 doi: 10.1111/hae.13291
|
| 57 |
Chiara Gelli, Mirko Tarocchi, Ludovico Abenavoli, Laura Di Renzo, Andrea Galli, Antonino De Lorenzo. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(17): 3150-3162 doi: 10.3748/wjg.v23.i17.3150
|
| 58 |
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
|
| 59 |
Rosângela Passos de Jesus, Naiara Brunelle Oliveira Neiva, Thomas Thássio Rodrigues de Araújo Silva. A síndrome metabólica e suas implicações clínicas. 2018; : 139 doi: 10.7476/9786588211113.0007
|
| 60 |
A. Yu. Timakova, Yu. P. Skirdenko, M. A. Livzan, T. S. Krolevets, N. A. Nikolaev, A. V. Nelidova. Cardiovascular comorbidity in non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2020; (10): 88 doi: 10.31146/1682-8658-ecg-182-10-88-95
|
| 61 |
Aqsa Qurban, Hamid Khan, Fizza Ali, Saba Abbas, Syeda Amber Hameed, Nousheen Hussain. Determine the Curing Effects of Silybum marianum (milk thistle) Administered Orally to Non-Alcoholic Fatty Liver Disease (NAFLD) Patients for Six Months. Pakistan BioMedical Journal 2023; : 27 doi: 10.54393/pbmj.v6i04.869
|
| 62 |
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2021; 115: 154455 doi: 10.1016/j.metabol.2020.154455
|
| 63 |
N. R. Matkovska. CHANGES IN CARBOHYDRATE METABOLISM AND ADIPOCYTOKINES UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADAMETHIONINUM AND ARGININE GLUTAMATE. Medical and Clinical Chemistry 2020; (3): 17 doi: 10.11603/mcch.2410-681X.2020.v.i3.11514
|
| 64 |
Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi, Isabella Franco, Tamara Lippolis, Rosalba D’Alessandro, Maria Grazia Refolo, Caterina Messa. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. International Journal of Molecular Sciences 2021; 22(8): 3899 doi: 10.3390/ijms22083899
|
| 65 |
Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa, Koshi Nakamura, Takafumi Nakagawa, Yasuo Terauchi, Akiko Tamakoshi, Tatsuya Atsumi. Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study. Journal of Diabetes Investigation 2020; 11(4): 964 doi: 10.1111/jdi.13221
|
| 66 |
Francesco Azzaroli, Giuseppe Mazzella, Giulio Marchesini, Lucia Brodosi, Maria Letizia Petroni. Fatty liver in pregnancy: a narrative review of two distinct conditions. Expert Review of Gastroenterology & Hepatology 2020; 14(2): 127 doi: 10.1080/17474124.2020.1715210
|
| 67 |
Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, Marcello Dallio, Carmelina Loguercio, Laura Di Renzo, Antonino De Lorenzo. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. International Journal of Environmental Research and Public Health 2019; 16(17): 3011 doi: 10.3390/ijerph16173011
|
| 68 |
Ludovico Abenavoli, Lorenzo Romano, Paola Gualtieri, Gemma Lou De Santis, Antonino De Lorenzo. Pathology. 2020; : 255 doi: 10.1016/B978-0-12-815972-9.00025-1
|
| 69 |
Yuji Xiao, Xue Zhang, Dongxin Yi, Fangyi Qiu, Lei Wu, Yiyong Tang, Ningning Wang. Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1225946
|
| 70 |
Danijela Ristic-Medic, Marijana Kovacic, Marija Takic, Aleksandra Arsic, Snjezana Petrovic, Marija Paunovic, Maja Jovicic, Vesna Vucic. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease. Nutrients 2020; 13(1): 15 doi: 10.3390/nu13010015
|
| 71 |
Sven M. Francque, Alexander Hodge, Jerome Boursier, Ziad H. Younes, Gerardo Rodriguez-Araujo, Grace S. Park, Naim Alkhouri, Manal F. Abdelmalek. Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction–associated steatohepatitis. Hepatology Communications 2024; 8(2) doi: 10.1097/HC9.0000000000000335
|
| 72 |
Jung-Pyo Yang, Ji-Hun Shin, Seung-Hwan Seo, Sang-Gyun Kim, Sang Hyung Lee, Eun-Hee Shin. Effects of Antioxidants in Reducing Accumulation of Fat in Hepatocyte. International Journal of Molecular Sciences 2018; 19(9): 2563 doi: 10.3390/ijms19092563
|
| 73 |
Xin Xin, Cheng Chen, Yi-Yang Hu, Qin Feng. Protective effect of genistein on nonalcoholic fatty liver disease (NAFLD). Biomedicine & Pharmacotherapy 2019; 117: 109047 doi: 10.1016/j.biopha.2019.109047
|
| 74 |
Thomas Ebert, Nicolas Linder, Alexander Schaudinn, Harald Busse, Joachim Berger, Ralf Lichtinghagen, Volker Keim, Johannes Wiegand, Thomas Karlas. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease. Endocrine 2017; 58(2): 246 doi: 10.1007/s12020-017-1417-z
|
| 75 |
Hannah L. Mayr, Jaimon T. Kelly, Graeme A. Macdonald, Ingrid J. Hickman. ‘Focus on diet quality’: a qualitative study of clinicians’ perspectives of use of the Mediterranean dietary pattern for non-alcoholic fatty liver disease. British Journal of Nutrition 2022; 128(7): 1220 doi: 10.1017/S0007114521001100
|
| 76 |
Pegah Golabi, Maria Stepanova, Huong T Pham, Rebecca Cable, Nila Rafiq, Haley Bush, Trevor Gogoll, Zobair M Younossi. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD). BMJ Open Gastroenterology 2018; 5(1): e000198 doi: 10.1136/bmjgast-2018-000198
|
| 77 |
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytotherapy Research 2018; 32(11): 2202 doi: 10.1002/ptr.6171
|
| 78 |
Yoshio Sumida, Masato Yoneda, Yuji Ogawa, Masashi Yoneda, Takeshi Okanoue, Atsushi Nakajima. Current and new pharmacotherapy options for non-alcoholic steatohepatitis. Expert Opinion on Pharmacotherapy 2020; 21(8): 953 doi: 10.1080/14656566.2020.1744564
|
| 79 |
Yu-Rim Chae, Yu Ra Lee, Young-Soo Kim, Ho-Young Park. Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome. Journal of Microbiology and Biotechnology 2024; 34(4): 747 doi: 10.4014/jmb.2312.12031
|
| 80 |
Ying-Jen Chen, Jiann-Torng Chen, Ming-Cheng Tai, Chang-Min Liang, Yuan-Yuei Chen, Tung-Wei Kao, Wen-Hui Fang, Wei-Liang Chen. Examining the associations among intraocular pressure, hepatic steatosis, and anthropometric parameters. Medicine 2019; 98(43): e17598 doi: 10.1097/MD.0000000000017598
|
| 81 |
Nindy Sabrina, Chyi-Huey Bai, Chun-Chao Chang, Yi-Wen Chien, Jiun-Rong Chen, Jung-Su Chang. Serum Iron:Ferritin Ratio Predicts Healthy Body Composition and Reduced Risk of Severe Fatty Liver in Young Adult Women. Nutrients 2017; 9(8): 833 doi: 10.3390/nu9080833
|
| 82 |
Gang Li, Rafael S. Rios, Xin-Xin Wang, Yue Yu, Kenneth I. Zheng, Ou-Yang Huang, Liang-Jie Tang, Hong-Lei Ma, Yi Jin, Giovanni Targher, Christopher D. Byrne, Xiao-Yan Pan, Ming-Hua Zheng. Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. British Journal of Nutrition 2022; 127(11): 1613 doi: 10.1017/S0007114521002415
|
| 83 |
Mona Hegazy, Naglaa M. Elsayed, Hala M. Ali, Hanan G. Hassan, Laila Rashed. Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link?. Journal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/5267025
|
| 84 |
H.G. Ağalar. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 175 doi: 10.1016/B978-0-12-816488-4.00009-7
|
| 85 |
Eun-Hee Jang, Yoosoo Chang, Seungho Ryu, Seolhye Kim, Young Hwan Kim, Ki-Chul Sung, Yong Kyun Cho, Soo-Jin Lee, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne. Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study. Journal of Clinical Medicine 2019; 8(5): 610 doi: 10.3390/jcm8050610
|
| 86 |
Min Zhang, Su Lin, Ming-fang Wang, Jiao-feng Huang, Shi-ying Liu, Su-mei Wu, Hao-yang Zhang, Zi-mu Wu, Wen-Yue Liu, Dong-Chu Zhang, Chuan-ming Hao, Yue-yong Zhu, Ming-Hua Zheng, Xiao-zhong Wang. Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01278-z
|
| 87 |
Riina Harjumäki, Chris S. Pridgeon, Magnus Ingelman-Sundberg. CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload. International Journal of Molecular Sciences 2021; 22(15): 8221 doi: 10.3390/ijms22158221
|
| 88 |
Dustin E. Bosch, Matthew M. Yeh. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease. Human Pathology 2017; 69: 55 doi: 10.1016/j.humpath.2017.09.008
|
| 89 |
Carmela Colica, Ludovico Abenavoli. Resistin levels in non-alcoholic fatty liver disease pathogenesis. Journal of Translational Internal Medicine 2018; 6(1): 52 doi: 10.2478/jtim-2018-0011
|
| 90 |
Chang-Xi Chen, Yu-Shan Mao, Parker Foster, Zhong-Wei Zhu, Juan Du, Chuan-Yong Guo. Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease. Applied Physiology, Nutrition, and Metabolism 2017; 42(3): 295 doi: 10.1139/apnm-2016-0499
|
| 91 |
Nazila Garousi, Babak Tamizifar, Makan Pourmasoumi, Awat Feizi, Gholamreza Askari, Cain C. T. Clark, Mohammad Hasan Entezari. Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial. Archives of Physiology and Biochemistry 2023; 129(4): 975 doi: 10.1080/13813455.2021.1890128
|
| 92 |
Hashimoto Yoshitaka, Masahide Hamaguchi, Takao Kojima, Takuya Fukuda, Akihiro Ohbora, Michiaki Fukui. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease. Medicine 2017; 96(18): e6712 doi: 10.1097/MD.0000000000006712
|
| 93 |
Shunming Zhang, Yeqing Gu, Shanshan Bian, Magdalena J. Górska, Qing Zhang, Li Liu, Ge Meng, Zhanxin Yao, Hongmei Wu, Yawen Wang, Tingjing Zhang, Xuena Wang, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Lu Qi, Kaijun Niu. Dietary patterns and risk of non-alcoholic fatty liver disease in adults: A prospective cohort study. Clinical Nutrition 2021; 40(10): 5373 doi: 10.1016/j.clnu.2021.08.021
|
| 94 |
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients 2017; 9(4): 387 doi: 10.3390/nu9040387
|
| 95 |
Changxi Chen, Zhongwei Zhu, Yushan Mao, Yimin Xu, Juan Du, Xiaoping Tang, Hongbao Cao. HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. Bioscience Reports 2020; 40(1) doi: 10.1042/BSR20193996
|
| 96 |
Yoshitaka Hashimoto, Masahide Hamaguchi, Takuya Fukuda, Akihiro Ohbora, Takao Kojima, Michiaki Fukui. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 2017; 57(1): 89 doi: 10.1007/s12020-017-1313-6
|
| 97 |
Sergey S. POPOV, Evgenii D. KRYL’SKII, Konstantin K. SHULGIN, Ekaterina A. RASKINA, Tatyana N. POPOVA, Alexander N. PASHKOV, Galina N. KUPTSOVA. Inflammation is associated with impairment of oxidative status, carbohydrate and lipid metabolism in type 2 diabetes complicated by non-alcoholic fatty liver disease. Minerva Endocrinology 2022; 47(3) doi: 10.23736/S2724-6507.20.03257-5
|
| 98 |
Ilka Ratjen, Jakub Morze, Janna Enderle, Marcus Both, Jan Borggrefe, Hans-Peter Müller, Jan Kassubek, Manja Koch, Wolfgang Lieb. Adherence to a plant-based diet in relation to adipose tissue volumes and liver fat content. The American Journal of Clinical Nutrition 2020; 112(2): 354 doi: 10.1093/ajcn/nqaa119
|
| 99 |
Marta Hernández-Conde, Elba Llop, Carlos Fernández Carrillo, Beatriz Tormo, Javier Abad, Luis Rodriguez, Christie Perelló, Marta López Gomez, José Luis Martínez-Porras, Natalia Fernández Puga, Maria Trapero-Marugan, Enrique Fraga, Carlos Ferre Aracil, José Luis Calleja Panero. Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2020; 26(42): 6658-6668 doi: 10.3748/wjg.v26.i42.6658
|
| 100 |
Ludovico Abenavoli, Emidio Scarpellini, Carmela Colica, Luigi Boccuto, Bahare Salehi, Javad Sharifi-Rad, Vincenzo Aiello, Barbara Romano, Antonino De Lorenzo, Angelo A. Izzo, Raffaele Capasso. Gut Microbiota and Obesity: A Role for Probiotics. Nutrients 2019; 11(11): 2690 doi: 10.3390/nu11112690
|
| 101 |
Hao Lv, Yang Liu. Management of non-alcoholic fatty liver disease: Lifestyle changes. World Journal of Gastroenterology 2024; 30(22): 2829-2833 doi: 10.3748/wjg.v30.i22.2829
|
| 102 |
R Guo, S Nair, Y Zhang, J Ren. RETRACTED ARTICLE: Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis. International Journal of Obesity 2017; 41(9): 1403 doi: 10.1038/ijo.2017.128
|
| 103 |
Yeon-Hui Jeong, Haeng Hur, Eun-Joo Jeon, Su-Jin Park, Jin Hwang, Ae Lee, Kyong Lee, Mi Sung. Honokiol Improves Liver Steatosis in Ovariectomized Mice. Molecules 2018; 23(1): 194 doi: 10.3390/molecules23010194
|
| 104 |
Ludovico Abenavoli, Marta Greco, Natasa Milic, Francesca Accattato, Daniela Foti, Elio Gulletta, Francesco Luzza. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. Nutrients 2017; 9(8): 870 doi: 10.3390/nu9080870
|
| 105 |
Yu-Ting Wei, Peng-Yi Lee, Cheng-Yu Lin, Hsuan-Ju Chen, Che-Chen Lin, Jin-Shang Wu, Yin-Fan Chang, Chen-Long Wu, How-Ran Guo. Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1178-7
|
| 106 |
David Hermanus Wessels, Zeil Rosenberg. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?. World Journal of Hepatology 2021; 13(2): 233-241 doi: 10.4254/wjh.v13.i2.233
|
| 107 |
Shujun Zhang, Tingting Du, Mengni Li, Huiming Lu, Xuan Lin, Xuefeng Yu. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. Medicine 2017; 96(12): e6381 doi: 10.1097/MD.0000000000006381
|
| 108 |
Chihiro Nakashita, Lu Xi, Yasushi Inoue, Ryota Kabura, Shota Masuda, Yuko Yamano, Takahiko Katoh. Impact of dietary compositions and patterns on the prevalence of nonalcoholic fatty liver disease in Japanese men: a cross-sectional study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01919-x
|
| 109 |
Dimitrios A. Koutoukidis, Susan A. Jebb, Paul Aveyard, Nerys M. Astbury. The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial. Obesity Facts 2020; 13(2): 144 doi: 10.1159/000505667
|
| 110 |
Natalia Belemets, Nazarii Kobyliak, Tetyana Falalyeyeva, Olena Kuryk, Oksana Sulaieva, Tetyana Vovk, Tetyana Beregova, Liudmila Ostapchenko. Polyphenol Compounds Melanin Prevented Hepatic Inflammation in Rats with Experimental Obesity. Natural Product Communications 2018; 13(11) doi: 10.1177/1934578X1801301118
|
| 111 |
Dalong Zhang, Dianming Zhou, Xiaojun Wang, Min Li, Jing Zhang, Ning He, Xiaoli Zhou, Zhenshu Li, Guowei Huang, Wen Li, Zhiyong Qian. Selenium and vitamin B2 cosupplementation alleviates high‐fat‐diet‐induced nonalcoholic fatty liver disease in rats by regulating hepatic lipid metabolism. European Journal of Lipid Science and Technology 2024; 126(1) doi: 10.1002/ejlt.202300020
|
| 112 |
Samukelisiwe C. Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, Abidemi P. Kappo, Albertus K. Basson, Carmen Pheiffer, Rabia Johnson. The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling. Biomedicine & Pharmacotherapy 2020; 131: 110785 doi: 10.1016/j.biopha.2020.110785
|
| 113 |
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li, Lin Wang. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020; 330: 109199 doi: 10.1016/j.cbi.2020.109199
|
| 114 |
Tannaz Eslamparast, Puneeta Tandon, Maitreyi Raman. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(8): 800 doi: 10.3390/nu9080800
|
| 115 |
Fengyun Wen, Zhuoyan Shi, Xiaoping Liu, Yuguang Tan, Lan Wei, Xuemin Zhu, Hui Zhang, Xiaohuan Zhu, Xiangmiao Meng, Weixia Ji, Mengting Yang, Zhaoxuan Lu. Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice. Hormone and Metabolic Research 2021; 53(02): 132 doi: 10.1055/a-1293-8250
|
| 116 |
Alina Suciu, Ludovico Abenavoli, Rinaldo Pellicano, Francesco Luzza, Dan L. Dumitrascu. Transaminases: oldies but goldies. A narrative review. Minerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02660-4
|
| 117 |
Cora Watzinger, Tobias Nonnenmacher, Mirja Grafetstätter, Solomon A. Sowah, Cornelia M. Ulrich, Hans-Ullrich Kauczor, Rudolf Kaaks, Ruth Schübel, Johanna Nattenmüller, Tilman Kühn. Dietary Factors in Relation to Liver Fat Content: A Cross-sectional Study. Nutrients 2020; 12(3): 825 doi: 10.3390/nu12030825
|
| 118 |
Ludovico Abenavoli, Tiziana Larussa, Alessandro Corea, Anna Caterina Procopio, Luigi Boccuto, Marcello Dallio, Alessandro Federico, Francesco Luzza. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(2): 494 doi: 10.3390/nu13020494
|
| 119 |
Juan Li, Lv Zhu, Yu-mei Zhang, Huan Chen, Yi-fan Miao, Hong-xin Kang, Hong-yu Ren, Mei-hua Wan, Dan Long, Wen-fu Tang, Caigan Du. Sheng‐Jiang Powder Ameliorates High Fat Diet Induced Nonalcoholic Fatty Liver Disease via Inhibiting Activation of Akt/mTOR/S6 Pathway in Rats. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/6190254
|
| 120 |
Saman Khalatbari-Soltani, Pedro Marques-Vidal, Fumiaki Imamura, Nita G. Forouhi. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study. BMJ Open 2020; 10(12): e040959 doi: 10.1136/bmjopen-2020-040959
|
| 121 |
Tingting Zhou, Ligang Cao, Yimei Du, Lin Qin, Yanliu Lu, Qianru Zhang, Yuqi He, Daopeng Tan. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism. PeerJ 2023; 11: e15225 doi: 10.7717/peerj.15225
|
| 122 |
Wenlan Zou, Chen Zhang, Xuefang Gu, Xiaohong Li, Huiming Zhu. Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats. Drug Design, Development and Therapy 2021; : 2565 doi: 10.2147/DDDT.S307257
|
| 123 |
Aleksandra Klisic, Ludovico Abenavoli, Sharmila Fagoonee, Nebojsa Kavaric, Gordana Kocic, Ana Ninić. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. Minerva Medica 2019; 110(3) doi: 10.23736/S0026-4806.19.05978-0
|
| 124 |
Ludovico Abenavoli, Laura Di Renzo, Luigi Boccuto, Nuha Alwardat, Santo Gratteri, Antonino De Lorenzo. Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2018; 12(9): 873 doi: 10.1080/17474124.2018.1503947
|
| 125 |
Byunghun So, Li Li Ji, Saba Imdad, Chounghun Kang, Marcia B. Aguila. Proteomic analysis of the effect of high-fat-diet and voluntary physical activity on mouse liver. PLOS ONE 2022; 17(8): e0273049 doi: 10.1371/journal.pone.0273049
|
| 126 |
Getachew Debas Belew, John G. Jones. De novo lipogenesis in non‐alcoholic fatty liver disease: Quantification with stable isotope tracers. European Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13733
|
| 127 |
Ulla Nivukoski, Markus Niemelä, Aini Bloigu, Risto Bloigu, Mauri Aalto, Tiina Laatikainen, Onni Niemelä. Combined effects of lifestyle risk factors on fatty liver index. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01270-7
|
| 128 |
Sara De Nucci, Roberta Rinaldi, Martina Di Chito, Rossella Donghia, Vito Giannuzzi, Endrit Shahini, Raffaele Cozzolongo, Pasqua Letizia Pesole, Sergio Coletta, Giovanni De Pergola, Gianluigi Giannelli. The Replacement of Only One Portion of Starchy Carbohydrates with Green Leafy Vegetables Regresses Mid and Advanced Stages of NAFLD: Results from a Prospective Pilot Study. Nutrients 2023; 15(10): 2289 doi: 10.3390/nu15102289
|